Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (3): 18-25.doi: 10.6040/j.issn.1671-7554.0.2020.1135
Previous Articles Next Articles
LUO Huichen1, HU Danhui2, ZHANG Ji3
CLC Number:
[1] Tu Y, Guo R, Li J, et al. MiRNA regulation of MIF in SLE and attenuation of murine lupus nephritis with miR-654[J]. Front Immunol, 2019, 10: 2229. doi: 10.3389/fimmu.2019.02229. [2] Miguel DF, Terreri MT, Pereira RMR, et al. Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis[J]. Adv Rheumatol, 2020, 60(1):10. doi: 10.1186/s42358-020-0114-4. [3] 王艳艳, 王嫱, 欧阳春. miR-203在系统性红斑狼疮患者外周血单个核细胞中的表达及临床意义[J]. 南京医科大学学报(自然科学版), 2015, 35(11): 1594-1596. WANG Yanyan, WANG Qiang, OUYANG Chun. Expression of miR-203 in peripheral blood mononuclear cells in patients with systemic lupus erythematosus[J]. Acta Universitatis Medicicinalis Nanjing(Natural Science), 2015, 35(11): 1594-1596. [4] Gao S, Yi Y, Xia G, et al. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases[J]. Autoimmun Rev, 2019, 18(1): 25-35. [5] Du Y, Wu T, Zhou XJ, et al. Blockade of CD354(TREM-1)ameliorates anti-GBM-induced nephritis[J]. Inflammation, 2016, 39(3): 1169-1176. [6] Dubash AD, Kam CY, Aguado BA, et al. Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes[J]. J Cell Biol, 2016, 212(4): 425-438. [7] 汪洪, 陈丽, 刘春燕, 等. 狼疮性肾炎患者血清TGF-β1、CysC、sTM水平变化及其与预后的关系[J]. 西部医学, 2020, 32(2): 242-245. WANG Hong, CHEN Li, LIU Chunyan, et al. Changes of levels of serum TGF-β1, CysC and sTM and their relationship with prognosis in patients with lupus nephritis[J]. Medical Journal of West China, 2020, 32(2): 242-245. [8] Chandan K, Gupta M, Sarwat M. Role of host and pathogen-derived microRNAs in immune regulation during infectious and inflammatory diseases[J]. Front Immunol, 2020, 10:3081. doi: 10.3389/fimmu.2019.03081. [9] Assmann TS, Recamonde-Mendoza M, de Souza BM, et al. MicroRNAs and diabetic kidney disease: systematic review and bioinformatic analysis[J]. Mol Cell Endocrinol, 2018, 477: 90-102. doi: 10.1016/j.mce.2018.06.005. [10] 吕婕, 李珉珉. 尿外泌体microRNAs在肾脏疾病中的研究进展[J]. 中国病理生理杂志, 2020, 36(2): 378-384. LYU Jie, LI Minmin. Progress of urinary exsome microRNAs in kidney diseases[J]. Chinese Journal of Pathophysiology, 2020, 36(2): 378-384. [11] Fan Y, Chen H, Huang Z, et al. Emerging role of miRNAs in renal fibrosis[J]. RNA Biol, 2020, 17(1): 1-12. [12] Zhang L, Zhang X. Downregulated miR-203 attenuates IL-β, IL-6, and TNF-α activation in TRAF6-treated human renal mesangial and tubular epithelial cells[J]. Int J Clin Exp Pathol, 2020, 13(2): 324-331. [13] Aziz F, Chaudhary K. Lupus nephritis: a treatment update[J]. Curr Clin Pharmacol, 2018, 13(1): 4-13. [14] Liu F, Zhang X, Zhang B, et al. TREM1: a positive regulator for inflammatory response via NF-κB pathway in A549 cells infected with Mycoplasma pneumonia[J]. Biomed Pharmacother, 2018, 107: 1466-1472. doi:10.1016/j. biopha.2018.07.176. [15] Shi X, Zhang Y, Wang H, et al. Effect of triggering receptor expressed on myeloid cells 1(TREM-1)blockade in rats with cecal ligation and puncture(CLP)-induced sepsis[J]. Med Sci Monit, 2017, 23: 5049-5055. doi: 10.12659/ msm.904386. [16] Bassyouni IH, Fawzi S, Gheita TA, et al. Clinical association of a soluble triggering receptor expressed on myeloid cells-1(sTREM-1)in patients with systemic lupus erythematosus[J]. Immunol Invest, 2017, 46(1): 38-47. [17] Anders HJ, Saxena R, Zhao MH, et al. Lupus nephritis[J]. Nat Rev Dis Primers, 2020, 6(1): 7. doi: 10.1038/s41572-019-0141-9. [18] 于翔, 戴铭卉, 刘猛, 等. 通腑泄浊法对慢性肾脏病大鼠TGF-β1/p38MAPK信号通路的调节作用[J]. 中成药, 2019, 41(5): 1000-1005. YU Xiang, DAI Minghui, LIU Meng, et al. Regulatory effects of discharging fu-organ and removing turbidity method on TGF-β1/p38MAPK signaling pathway in chronic kidney disease rats[J]. Chinese Traditional Patent Medicine, 2019, 41(5): 1000-1005. [19] Gu LY, Sun Y, Tang HT, et al. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway [J]. J Ethnopharmacol, 2020: 113548. doi: 10.1016/j.jep.2020.113548. [20] Lu H, Chen B, Hong W, et al. Transforming growth factor-β1 stimulates hedgehog signaling to promote epithelial-mesenchymal transition after kidney injury[J]. FEBS J, 2016, 283(20): 3771-3790. [21] 丁华琳, 李扬扬, 于丰源, 等. 达格列净通过Klotho/TGF-β1通路抑制糖尿病肾病大鼠肾纤维化的作用[J]. 山东大学学报(医学版), 2020, 58(3): 75-80. DING Hualin, LI Yangyang, YU Fengyuan, et al. Dalixamine inhibits renal fibrosis in rats with diabetic nephropathy via Klotho/TGF-β1 signaling pathway[J]. Journal of Shandong University(Health Sciences), 2020, 58(3): 75-80. [22] Gao F, Wang Y, Li S, et al. Inhibition of p38 mitogen-activated protein kinases attenuates renal interstitial fibrosis in a murine unilateral ureteral occlusion model[J]. Life Sci, 2016, 167: 78-84. doi: 10.1016/j.lfs.2016.10.022. [23] 程闰夏, 杨琳琳, 林云, 等. p38MAPK信号通路与肾小球疾病关系的研究进展[J]. 山东医药, 2018, 58(14): 98-101. [24] 王秀袖. 尿液中 TGF-β1、Kim-1、Cys-C 水平与狼疮性肾炎患者病理类型肾脏病理分级及病情的关系[J]. 中国卫生检验杂志, 2019, 29(7): 829-831. WANG Xiuxiu. Relationship between TGF-β1, Kim-1, Cys-C levels in urine and pathological type, pathological grading and condition of lupus nephritis[J]. Chinese Journal of Health Laboratory Technology, 2019, 29(7): 829-831. [25] Hong F, Wu N, Ge Y, et al. Nanosized titanium dioxide resulted in the activation of TGF-β/Smads/p38MAPK pathway in renal inflammation and fibration of mice[J]. J Biomed Mater Res A, 2016, 104(6): 1452-1461. |
[1] | KAN Nana, YU Lichun, SUN Shuzhen, LI Qian, LUAN Chunli. Clinics, pathology and prognosis of 30 children with nephrotic syndrome in clinical trials of lupus nephritis [J]. Journal of Shandong University (Health Sciences), 2020, 58(2): 54-59. |
[2] | MA Zhenzhen, SUN Hongsheng, YANG Qingrui. Changes and clinical significance of serum adipokines in systemic lupus erythematosus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 86-90. |
|